SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine

Background: At variance to humoral responses, cellular immunity after anti-SARS-CoV-2 vaccines has been poorly explored in recipients of allogeneic hematopoietic stem-cell transplantation (Allo-HSCT), especially within the first post-transplant years where immunosuppression is more profound and harm...

Descripción completa

Detalles Bibliográficos
Autores principales: Clémenceau, Béatrice, Guillaume, Thierry, Coste-Burel, Marianne, Peterlin, Pierre, Garnier, Alice, Le Bourgeois, Amandine, Jullien, Maxime, Ollier, Jocelyn, Grain, Audrey, Béné, Marie C., Vié, Henri, Chevallier, Patrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950166/
https://www.ncbi.nlm.nih.gov/pubmed/35335079
http://dx.doi.org/10.3390/vaccines10030448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950166/
https://www.ncbi.nlm.nih.gov/pubmed/35335079
http://dx.doi.org/10.3390/vaccines10030448

Ejemplares similares